Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 5;16(10):e0247245. doi: 10.1371/journal.pone.0247245

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India

Chandra Kumar Dolla 1,*, Bhaskaran Dhanaraj 2, Padmapriyadarsini Chandrasekaran 2, Sriram Selvaraj 1, Pradeep Aravindan Menon 1, Kannan Thiruvengadam 3, Rajendran Krishnan 3, Rajesh Mondal 4, Muniyandi Malaisamy 5, Srinivasa B Marinaik 1, Lakshmi Murali 6, Srikanth Prasad Tripathy 7
Editor: Frederick Quinn8
PMCID: PMC8491886  PMID: 34610012

Abstract

Background

Tuberculosis (TB) prevalence surveys add to the active case detection in the community level burden of TB both national and regional levels. The aim of this study was to assess the prevalence of bacteriologically confirmed pulmonary tuberculosis (PTB) in the community.

Methods

Household community-based tuberculosis disease survey was conducted targeting 69054 population from 43 villages of 5 blocks in Tiruvallure district adopting cluster sampling methodology of ≥15 years old adult rural population of South India during 2015–2018. All eligible individuals with suspected symptoms of PTB were screened with chest X-ray. Two sputum specimens (one spot and the other early morning sample) were collected for M.tb smear and culture examination. Conversely demographical, smoking and alcohol drinking habits information were also collected to explore the risk factor. Stepwise logistic regression was employed to associate risk factors for PTB.

Results

A total of 62494 were screened among 69054 eligible population, of whom 6340 were eligible for sputum specimen collection. Sputum for M.tb smear and culture examination were collected in 93% of participants. The derived prevalence of PTB was 307/100000 population (smear-positive 130; culture positive 277). As expected that PTB has decreased substantially compared to preceding surveys and it showed that older age, male, low BMI, diabetes, earlier history of TB and alcohol users were significantly associated (p < .0001) with an increased risk of developing PTB.

Conclusion

Upshot of the active survey has established a reduction in the prevalence of PTB in the rural area which can be accredited to better programmatic implementation and success of the National TB Control Programme in this district. It also has highlighted the need for risk reduction interventions accelerate faster elimination of TB.

Introduction

The National Strategic Plan (NSP) for TB 2017–2025 prepared by the Ministry of Health and Family Welfare, Government of India in consultation with 150 national and international public health experts, program managers, donor agencies, technical partners, civil societies, community representatives and other stakeholders in TB control both from the public as well as the private sector [1]. One of the goals of NSP 2017–2025 was to conduct the TB prevalence surveys to monitor the National TB Elimination Programme. There is an over-all epidemiological dissimilarity in TB prevalence between urban, and rural areas. While the urban TB prevalence surveys are characterized by an inferior TB prevalence with moderate annual risk, while rural areas revealed higher TB prevalence with lower annual risk [1] The diversity of TB epidemiology in the country necessitates a periodic measure of the burden of TB for addressing the problem. Tuberculosis burden estimate expert Peter J Dodd expressed the importance of disease burden estimates, which would suggest advocacy, scheduling, ranking, development assistance funding applications and allocating resources to monitor progress at the global level towards End TB strategy [2].

Since 1968, the world recognized 15-year old Bacillus Chalmette Guerin (BCG) vaccine trial was conducted by ICMR-National Institute for Research in Tuberculosis (NIRT), Chennai in the Thiruvallur district of Tamil Nadu, south India [3,4]. This population was monitored intensively by subsequent active community surveys over a period of fifty years, which evaluated the disease burden of tuberculosis—where the present survey was carried out to estimate the PTB burden. The survey followed methodology of preceding surveys and the statistical procedure suggested by WHO guideline [5].

Methodology

Study area

The National Institute for Research in Tuberculosis, one of the ICMR institutes, conducted a series of TB prevalence surveys in Thiruvallur district in the southern part of India since 1968. Thiruvallur is located about 50 kilometres from Chennai and includes five administrative blocks with 3,728,104 population. It has 17 Peripheral Health Institutions (PHIs) and two government general hospitals. The scientifically established the community-based Tuberculosis (TB) prevalence survey commenced on July 15, 2015, to study the geographical distribution of tuberculosis cases in it. The required sample population was selected with prior prevalence (3/1000) and adopting cluster randomization through probability proportional sampling design including block design concept. Census commenced targeting 69054 population from 47 villages of 5 blocks at Thiruvallure district. Apart from this, the household contacts aged 15 years and below of confirmed TB cases in the family, were included in this survey. The eligible population was aged ≥15 years, both males and females from the rural villages were contacted at their residence by the study team and the purpose of the screening was explained to them in the local language. An informed written consent was obtained from the participant after ascertaining their willingness.

Sampling design and sample size

Community-based cross-sectional study was planned in the villages/urban areas in the five blocks of Thiruvallur district. A multistage stratified cluster sampling design was adopted to select the clusters. The study area was stratified according to the blocks and the total sample size was proportionally allocated to the blocks. The clusters here were the villages/wards in rural/urban areas respectively. The sample size was proportionally allocated to 5 blocks and the clusters within the blocks were selected by a simple random sampling method. In the selected cluster, all the households were covered.

The earlier prevalence surveys in the study area (from 1999 to 2008) showed a declining trend in the culture positive TB prevalence with an annual reduction rate of 5.8%. Assuming the same annual reduction rate, it was estimated that in 2015, the culture positive TB prevalence will be 255 per 100,000 population. Assuming this prevalence rate, a precision of 20%, with a 95% confidence level, design effect of 2 and coverage of 90%, the sample size was estimated to be 83,155 which is approximately 84,000. Assuming the same annual reduction rate and based on the prevalence trend in the survey area, it was estimated that a population of 100867 was needed for this community survey to achieve the adult population.

Community preparedness

Before the survey was initiated, the researcher did k community preparedness. The study team including supervisor, Doctors, Statisticians, field supervisors, field investigators visited each selected village and met village leaders and explained about the study purpose and procedures to assist our survey team and extend hassle-free coordination between local villagers and research team. The village maps were collected and the sketch of the streets and lanes were prepared for census operation. The entire team was divided into four groups i.e. census enumeration, screening, sputum team and x-ray teams.

Survey procedures

Survey procedures were carried out according to standard operating procedures (SOP) followed by the previous surveys by a trained team of enumerators, symptom elicitors, X-ray technicians, sputum collectors, planners, and supervisors. All members of the team were well trained, experience ranging about 15 years to 30 years in the field in the past TB prevalence survey. All the staff involved in this study were trained in survey methods uniformly as per the current protocol and implemented. A team member interviewed every member of the house about their health status relevant to TB related symptoms like cough that lasts 3 weeks or longer, pain in the chest for ≥1 month, coughing up blood or sputum, weakness or fatigue, weight loss, no appetite, chills, unexplained fever for ≥1 month and sweating at night. Also information of demography, smoking and drinking habits were collected and fed in the server using a pre-formatted android Personal Digital Assistant (PDA) to explore the risk factor. The team member sent every adult of the household to mobile X-ray car for X-ray screening and made a notecard to sputum team for sputum collection if they had any clinical symptom on the spot. The laboratory procedures and reading of digital X-rays were performed by experienced qualified doctors of NIRT.

Enumeration and registration

The prearranged feasibility to conduct a survey in the community during early morning and late evenings hours of a day, in order to meet all the household members to maximise the coverage of the targeted population. The survey team went to every household and started with marking household number, which was unique to this survey for future reference. Each enrolled individual was assigned a unique identification (ID) number and directed registration to screen the participants according to the presence of on spot clinical symptoms of TB for sputum collection.

Digital X-ray screening for TB

The X-ray team contented three members’ one X-ray technician, one well-trained laptop operator where the digital X-ray directly displayed from the X-rays machine and one patient handler. The X-ray technician was trained to follow the standardized procedure of X-ray handling to the individual subjects. All eligible household members were directed by enumerators to X-ray car after notifying individual unique ID on the small white card to digital X-ray operator. Each registered individual was screened by a chest radiograph (digital X-ray) in the village through Mobile digital X-ray unit for TB after obtaining informed written consent for adult and assent for those less than 15 years. The radiographs were read independently by two readers and in case of disagreement, by a third reader. All individuals interviewed by trained field investigators for the presence of one or more of the symptoms suggestive of TB. History of anti-TB treatment previous/current anti-TB treatment was also elicited from each individual. For those with an abnormal chest radiograph and/or chest symptoms or previously diagnosed cases in the earlier surveys, two sputum samples (one spot and one early morning) were collected.

Sputum collection team

As directed by enumerator team, the patients those who had on spot clinical symptom and X-ray abnormality, the sputum team collected two sputa both in the early morning and on the spot sputum and stored in the sputum storage kit. The samples were sent to Laboratory while the related information card was sent to Epidemiology Statistical division for further coordination among laboratory and data entry process in Electronic Data Processing unit (EDP). Furthermore, this team also ensured patients on treatment and provided counseling to continue the treatment. All households in the entire cluster were systematically covered.

Laboratory investigations

Both the collected sputum along with clinical symptom and abnormal X-ray of each individual, were sent to the laboratory with sputum storage kit by sputum team. The sputum specimens were processed for smear fluorescent microscopy using auramine O stain, culture with solid culture using Lowenstein Jensen (L-J) medium. Samples were inoculated on slopes (two) of L-J medium and monitored every week for a period of eight weeks for growth. When there was no growth after eight weeks the culture was reported negative. Drug Susceptibility Testing (DST) was done for fist line anti-tuberculosis drugs (streptomycin, isoniazid, rifampicin and ethambutol) using Mycobacterium Growth Indicator Tube (MGIT).

Data management

The data collection and data management were adopted in this survey through Personal digital assistant (PDA), which was developed such way it could be used even in the interior rural villages where no internet facility was not available and implemented. The data were being collected in offline and syncing in the field station at the point of internet facility to NIRT’s central server, which could be viewed in the same day of data collected on a real-time database. The PDA application was developed by outsourcing, which contents of four modules i.e. Census taker, field investigator, X-ray taker, sputum collector and administrator modules. All the module users were given separate IDs and Password to collect independently. The interview schedule was installed in PDA and administered to collect information on demographic characteristics (age, sex), lifestyle characteristics (tobacco smoking, alcohol use), biomass fuel usage for cooking, clinical characteristics such as BCG scar, history of TB, and chest symptoms suggestive of TB. Further details for body mass index calculation; height in centimeters, weight in kilograms were measured. The hypertension was measured by a digital blood pressure monitor, diabetes by drug treatment history to all participants.

Definitions used

Smear positive TB

If the smear of either of the sputum specimen showed one or more acid-fast bacilli (AFB), irrespective of culture result.

Culture positive TB

If either of the specimens exhibited one or more colonies of M. tuberculosis, irrespective of smear result.

Bacteriologically positive TB

If at least one of the two specimens was a smear and/or culture positive.

Quality control

A quality check on symptom screening was done by a supervisor on a random sample of 10% of subjects. This was done independently without seeing the original card.

Statistical analysis

The data were collected through PDA and synced into NIRT’s central server, which was being monitored by Epidemiology Statistical unit on a real-time basis and immediate error verification after downloading all the modules data and merged and checked for completeness, errors by the statistical team on a daily basis. The error list was sent if any to the field unit for immediate correction, which found only a 1% error. Finally, the master data set was locked for analysis. The data were cleaned and checked missing information by using the checklist of the survey. The estimated prevalence of TB was stratified by smear-positive and culture positive. Initiated with data-driven methodology engaging each variable checking with variation, out layer and distributional assumption. Inception with univariate analysis and finally selected variable for multivariate technic stepwise logistic regression was employed for age, gender, BMI, diabetes, hypertension, history of TB tobacco smoking, alcohol consumption and cooking fuel used in the household, which was recorded as a categorical variable to engage the analysis by using SPSS 25.0 software (SPSS Inc., Chicago, IL, USA).

Ethical considerations

This study protocol was approved by the Institutional Ethics Committee of the National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai (IEC No: NIRT-IEC-2014032). All diagnosed TB patients were referred to the nearest NTEP for further management as per the guidelines.

Results

Coverage for screening

A total of 88080 population registered by the census for this survey. Out of these 69054 were met the eligibility criteria for screening TB. Among the eligible 90.5% (N = 62494) covered for screening (Fig 1). Of 69054 made attempt to screen, 6560 (9.5%) either refused or were not available during the survey.

Fig 1. Study population and its coverage.

Fig 1

Rationale for achieved power

The study power was achieved earlier part of this survey even though the planned 84000 samples were to be achieved but the study was stopped at this stage of completion 62494 were screened among 69054 eligible population from 43 clusters out of 47. The precision was comparatively high because we estimated power on the completed sample size, the type II error was minimum. In this case, the sample size was lesser than the estimated sample size. In this study, if the remaining 4 clusters were not surveyed the demographic prevalence of the disease or the information regarding the demographic prevalence was lacking even though the estimated power has been achieved in this completed population. The prevalence has been estimated on the planned sample size by the achieved population, which is scientifically rationale for comparison. The completed 62494 screened sample has been considered for analysis and estimation.

Prevalence of TB suspects

A total of 62494 screened, the prevalence of chest symptomatic suggestive TB was 7.7% (n = 4840), X-ray abnormality suggestive of TB was 2.5% (N = 1561) and persons with a previous history of TB was 0.9% (N = 544). We found that the overall prevalence of TB suspects in this population was 10.1% (N = 6340). It was observed that the prevalence of TB suspects was higher among the elderly population (X-ray abnormality was 7.1%; chest symptomatic 13.3%). With respect to gender, X-ray abnormality was almost similar (2.1% vs 2.9%) whereas chest symptoms (5.9% vs 9.8%) and history of TB (0.6% vs 1.2%) were higher in males as compared to females (Table 1).

Table 1. Study population and coverage for the prevalence survey.

Eligible population Population screened X-ray suggestive of TB Chest symptomatic History of TB Eligible for sputum collection Sputum collected
No No No % No % No % No % No %
Age Groups
15–34 29105 25938 116 0.4 1182 4.6 113 0.4 1383 5.3 1226 88.6
35–54 25251 22824 476 2.1 1825 8.0 242 1.1 2359 10.3 2183 92.5
≥ 55 14698 13732 969 7.1 1833 13.3 189 1.4 2598 18.9 2510 96.6
Gender
Female 35296 32956 692 2.1 1954 5.9 200 0.6 2658 8.1 2457 92.4
Male 33758 29538 869 2.9 2886 9.8 344 1.2 3682 12.5 3462 94.0
Total 69054 62494 1561 2.5 4840 7.7 544 0.9 6340 10.1 5919 93.4

Coverage for laboratory investigations

The proportion eligible for laboratory examination was 6340, among them 93.4% (N = 5919) sputum samples were collected. The coverage was similar in all age groups and in both genders (Table 1). Remaining 6.6% (N = 421) not able to collect sputum due to their inability to provide.

Overall prevalence of bacteriologically confirmed PTB

The total number of pulmonary tuberculosis cases detected in this survey was 192 (Table 2). The estimated prevalence of bacteriologically positive PTB was 307 per 100000 population. The prevalence of PTB increases as age increases (46 to 721 for 15–34 to above 55 years respectively). It was observed that a significantly higher prevalence of PTB among males than the females (85 vs 555). The overall prevalence of PTB was significantly high among persons with low BMI (892), persons with a previous history of TB (2778), diabetes (598), current smokers (1547), the intensity of smoke >20 cigarettes per day (2447) and alcohol users (1382).

Table 2. Estimated prevalence of TB and its associated risk factors.

Population Smear positive TB Culture positive TB Bacteriologically positive TB Prevalence of TB per 100000 pop. OR (95% CI) p-value aOR (95% CI) p-value
Smear positive Culture positive Bacteriologically positive
Age
15–34 25938 4 11 12 15 42 46 1 1
35–54 22824 43 73 81 188 320 355 7.79 (3.91–15.16) <0.001 8.92 (4.37–18.19) <0.001
≥ 55 13732 34 89 99 248 648 721 15.69 (7.93–31.06) <0.001 13.54 (6.66–27.51) <0.001
Gender
Female 32956 10 26 28 30 79 85 1 1
Male 29538 71 147 164 240 498 555 6.57 (4.11–10.50) <0.001 4.73 (2.91–7.68) <0.001
BCG Scar
No 37375 51 107 117 136 286 313 1
Yes 25119 30 66 75 119 263 299 0.95 (0.67–1.36) 0.792
BMI
≥18.5 52627 45 91 104 86 173 198 1 1
<18.5 9867 36 82 88 365 831 892 4.55 (3.40–6.07) <0.001 4.48 (3.26–6.15) <0.001
Diabetes
No 59818 73 157 176 122 262 294 1 1
Yes 2676 8 16 16 299 598 598 2.04 (1.17–3.56) 0.012 1.67 (0.99–2.83) 0.055
Hypertension
No 59561 76 166 184 128 279 309 1
Yes 2933 5 7 8 170 239 273 0.88 (0.46–1.71) 0.711
History of TB
No 61522 64 151 165 104 245 268 1 1
Yes 972 17 22 27 1749 2263 2778 10.62 (6.55–17.24) <0.001 3.64 (2.20–6.02) <0.001
Tobacco smoking
Never 56573 40 97 107 71 171 189 1 1
Current 4848 36 66 75 743 1361 1547 8.29 (5.87–11.71) <0.001 1.26 (0.83–1.93) 0.281
Past 1073 5 10 10 466 932 932 4.96 (2.78–8.86) <0.001
No of cigarettes/Beedies per day
Nil 56573 40 97 107 71 171 189 1
1_10 4372 25 46 52 572 1052 1189 6.35 (4.64–8.69) <0.001
11_20 792 8 11 12 1010 1389 1515 8.12 (4.12–16.01) <0.001
>20 757 8 19 21 1057 2510 2774 15.06 (8.12–27.91) <0.001
Alcohol consumption
No 52366 36 93 104 69 178 199 1 1
Current 9115 40 66 74 439 724 812 4.11 (2.88–5.88) <0.001 1.62 (1.14–2.32) 0.007
Yes 1013 5 14 14 494 1382 1382 7.04 (3.66–13.56) <0.001
Alcohol consumed (ml)
Nil 52366 52 126 139 99 241 265 1
<200ml 10128 29 47 53 286 464 523 3.02 (2.06–4.43) <0.001
Type of cooking fuel
Not Applicable 31020 18 50 54 58 161 174 1
Smokeless 16254 39 78 90 240 480 554 3.19 (2.29–4.46) <0.001
Smoke 15220 24 45 48 158 296 315 1.81 (1.04–3.18) 0.037
Overall 62494 81 173 192 130 277 307

Prevalence of smear-positive PTB

The prevalence of smear-positive PTB was 130 cases per 100000 population (Table 2). It was significantly high among persons aged ≥55, males, low BMI, diabetes, persons with the previous history of TB, current smokers, those who smoked >20 cigarettes per day and alcohol users (1382).

Prevalence of culture positive PTB

The prevalence of culture positive PTB was 277 cases per 100000 population (Table 2). It was significantly high among persons aged ≥55, males, low BMI, diabetes, persons with a previous history of TB, current smokers, those who smoked >20 cigarettes per day and alcohol users (1382).

Risk factors associated with bacteriologically PTB

Univariate analysis identified a wide range of factors associated with an increased risk of PTB (Table 2). Stepwise logistic regression analysis found that increasing age (aOR13.54, 95 CI 6.66–27.51, P = 0.001) male gender age (aOR 4.73, 95 CI 2.91–7.68, P = 0.001), low BMI (aOR 4.48, 95 CI 3.26–6.15; P = 0.001), diabetes (aOR 1.67, CI 0.99–2.83, P = 0.055), previous history of TB (aOR3.64, 95 CI 2.20–6.02, P = 0.001), and alcohol users (aOR 1.62, 95 CI 1.14–2.32, P = 0.007) were associated with an increased risk of developing PTB (Fig 2).

Fig 2. Risk factors associated with TB.

Fig 2

Discussion

The salient finding from this community survey that the prevalence of bacteriologically positive PTB was 307 per 100000 population. It was found to be varied in different socio-economic groups from 46 in 15–34 years of age group to 2778 per 100000 population those who had a previous history of TB. It was corroborated with the surveys conducted in other parts of the country which also reported that there is a regional variation of PTB prevalence that ranged from 171 to 528 per 100000 population and the pooled estimate of sub-national TB prevalence was 300 per 100000 [6]. Our study also found that almost similar prevalence to these estimates (300 vs 307).

However, this was higher as compared to other parts of the country Bangalore rural Karnataka [7], SAS Nagar (Punjab) [8], Wardha (Maharastra) [9], and Faridabad (Haryana) [10]. The prevalence was significantly less as compared to Gujarat (439.2) [11], Kanpur (481.1) [7], Banda (528.4) [7] and Jabalpur (337) [12]. This survey was done in rural areas of Thiruvallur District while comparing this prevalence of PTB within Tamil Nadu state it was significantly less as compared to urban Chennai (307 vs 357) [13].

With respect to community based PTB prevalence survey conducted in the same area, it was found that prevalence of smear-positive (130 vs 326, 259, 168, 180) and culture positive PTB (277 vs 607, 454, 309, 388) was significantly less in the current survey (2015–18) as compared to previous surveys done from 1999 to 2008 at two and half years intervals [1416]. It revealed that there was a reduction in smear-positive PTB by 60% reduction from 326 to 130 and reduction in culture positive PTB was 54.4% reduction during the 20 years’ time. It may be progression owing to the government’s intensive of TB control activities such as the implementation of Directory Observed Treatment Short-course, implementation of new diagnostic tools for early detection, repeated community survey to do active case finding and IEC programmes.

This study has established that increasing age, male gender, low BMI, diabetes, history of TB and alcohol consumption were the risk of developing PTB. These are the known risk factors that were reported from various studies [1721]. We rephrasing that there is a need to take appropriate action to modify among these modifiable risk factors, so that PTB reduction can be accelerated.

Prediction upon outcomes of this current study with the rational limitation that it was carried out at Thiruvallur district of the southern part of Tamil Nadu. It is required to contact the prevalence survey of PTB in other parts of the country for better understanding. The significance of this current study was that ICMR-NIRT had done repeated community-based PTB periodic prevalence surveys in the same area. This is a unique opportunity to find out the impact of the National TB Control Programme.

Conclusion

The current study, estimated community-based prevalence of bacteriologically confirmed PTB and its risk factors. This finding highlights that the study area continues to be a high TB burden area indicating the prevalence of 307 bacteriologically positive TB cases per 100000 population. The prevalence of PTB was significantly higher among the elderly population, males, those who have low BMI, diabetes, those who have had a previous history of TB and alcohol users. In addition, our finding demonstrates that there is a reduction in the prevalence of PTB in this area attributing for better implementation and success of the National TB Control Programme in this district. Our study suggests that there is a need to introduce risk reduction interventions to accelerate the reduction of PTB. Further, there is a need to conduct surveys to evaluate the sustainability of positive decline trend.

Acknowledgments

The authors are thankful to the Central TB Division, Ministry of Health and Family Welfare (MoHFW), Government of India and State TB Division, MoHFW, Government of Tamil Nadu given permission, and their overall coordination to undertake this TB prevalence survey. We acknowledge the Scientific Advisory Committee and Institutional Ethics Committee for their approval and their suggestions to improve the study. We are grateful to all Epidemiology field survey staff, Electronic Data Management Unit, Bacteriology laboratory for their support. We wish to express our deep gratitude to all participants in this survey.

Data Availability

All relevant data are within the paper.

Funding Statement

This study was supported by the World Health Organization as part of the MODEL DOTS project in the form of funding awarded to CKD and the Indian Council of Medical Research in the form of intramural funding awarded to CKD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.The Central TB Division (CTD), Ministry of Health and Family Welfare, Government of India. Revised National Tuberculosis Control Programme National Strategic Plan for Tuberculosis: 2017–25 Elimination by 2025. Ministry of Health with Family Welfare, Nirman Bhawan, New Delhi: 2017. [Google Scholar]
  • 2.Peter J Dodd, Commentary: The pros of plurality for tuberculosis burden estimates, International Journal of Epidemiology 2018; 47(5): 1560–1561. doi: 10.1093/ije/dyy147 [DOI] [PubMed] [Google Scholar]
  • 3.Tuberculosis Research Centre Chennai. Fifteen-year follow-up of trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res. 1999; 110:56–69. [PubMed] [Google Scholar]
  • 4.Adinarayanan S, Culp RK, Subramani R, Abbas KM, Radhakrishna S, Swaminathan S. Role of bacille Calmette-Guérin in preventing tuberculous infection. Int J Tuberc Lung Dis. 2017; 21(4):420–424. doi: 10.5588/ijtld.16.0833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Health Organization. Tuberculosis prevalence surveys:a handbook. World Health Organization, Geneva: 2011; WHO/HTM/TB/2010.17. [Google Scholar]
  • 6.Chadha V K, Kumar P, Anjinappa SM, et al. Prevalence of pulmonary tuberculosis among adults in a rural sub-district of South India. PLoS One 2012; 7(8): e42625. doi: 10.1371/journal.pone.0042625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chadha V K, Kumar P, Anjinappa SM, et al. Prevalence of pulmonary tuberculosis among adults in a rural sub-district of South India. PLoS One 2012; 7(8): e42625. doi: 10.1371/journal.pone.0042625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Aggarwal AN, Gupta D, Agarwal R, Sethi S, Thakur JS, Anjinappa SM, et al. Prevalence of pulmonary tuberculosis among adults in a north Indian district. PLoS One. 2015Feb19; 10(2):e0117363. doi: 10.1371/journal.pone.0117363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Narang P, Mendiratta DK, Tyagi NK, Jajoo UN, Tayade AT, Parihar PH, et al. Prevalence of pulmonary tuberculosis in Wardha district of Maharashtra, Central India. J Epidemiol Glob Health 2015; 29: S2210-6006(15)00035-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sharma SK, Goel A, Gupta SK, Mohan K, Sreenivas V, Rai SK, et al. Prevalence of tuberculosis in Faridabad district, Haryana State, India. Indian J Med Res. 2015; 141(2): 228–235. doi: 10.4103/0971-5916.155593 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.State TB Cell, Department of Health & Family Welfare, Government of Gujarat. Report on Population based survey to assess prevalence of pulmonary tuberculosis cases in the state of Gujarat, India (2011–12), December 2013.
  • 12.Rao VG, Bhat J, Yadav R, Gopalan GP, Nagamiah S, Bhondeley MK, et al. Prevalence of Pulmonary Tuberculosis—A Baseline Survey In Central India. PLoS ONE 2012; 7(8): e43225. doi: 10.1371/journal.pone.0043225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dhanaraj B, Papanna MK, Adinarayanan S, Vedachalam C, Sundaram V, Shanmugam S, et al. Prevalence and Risk Factors for Adult Pulmonary Tuberculosis in a Metropolitan City of South India. PLoS ONE 2015; 10(4): e0124260. doi: 10.1371/journal.pone.0124260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kolappan C, Subramani R, Chandrasekaran V, et al. Trend in tuberculosis infection prevalence in a rural area in South India after implementation of the DOTS strategy. The Int J Tuberc Lung Dis 2012; 16(10): 1315–19. doi: 10.5588/ijtld.12.0098 [DOI] [PubMed] [Google Scholar]
  • 15.Gopi PG, Subramani R, Radhakrishna S, et al. A baseline survey of the prevalence of tuberculosis in a community in South India at the commencement of a DOTS programme. Int J Tuberc Lung Dis 2003; 7: 1154–62. [PubMed] [Google Scholar]
  • 16.Subramani R, Radhakrishna S, Frieden TR, et al. Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India. Int J Tuberc Lung Dis 2008; 12: 916–20. [PubMed] [Google Scholar]
  • 17.Lonnroth K, Castro KG, Chakaya J M, et al. Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet 2010; 22:375(9728):1814–29. doi: 10.1016/S0140-6736(10)60483-7 [DOI] [PubMed] [Google Scholar]
  • 18.Kolappan C, Gopi PG, Subramani R, Narayanan PR. Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis 2007; 11 (9):999–1003. [PubMed] [Google Scholar]
  • 19.Jacobson J M. Alcoholism and tuberculosis. Alcohol Health Res World 1992; 16: 39–45. [Google Scholar]
  • 20.Shprykov AS, Zhadnov VZ. Effects of tobacco smoking on the course of infiltrative pulmonary tuberculosis and effectiveness of its treatment. Probl Tuberk 1994; (5):26–7. [PubMed] [Google Scholar]
  • 21.Shetty N, Shemko M, Vaz M, et al. An epidemiological evaluation of risk factors for tuberculosis in South India, a matched case control study. Int J Tuberc Lung Dis 2006; 10(1): 80–6. [PubMed] [Google Scholar]

Decision Letter 0

Frederick Quinn

6 Aug 2020

PONE-D-20-16942

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India

PLOS ONE

Dear Dr. Kumar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Frederick Quinn

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4.Thank you for stating the following in the Acknowledgments Section of your manuscript:

 [We are grateful for the financial and logistical support from the World Health Organisation, India

and Indian Council of Medical Research, Department of Health Research, MoHFW, New

Delhi.]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 [The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review of ms # PONE-D-20-16942 submitted to PLOS ONE by Kumar et. Al.

Tuberculosis remains one of the major respiratory diseases in southeast asia including the Indian subcontinent and a variety of environmental factors and co-morbidities determine not only the pathology of TB but also success of TB treatment. In this manuscript, Kumar et. al provide a summary of active TB surveillance done in the south Indian Thiruvallur district. Community based surveillance targeting ~69,000 individuals >15y of age included screening for pulmonary TB using sputum samples and chest X-rays. The authors also collected demographical information as well as smoking, alcohol consumption and established correlation with a positive TB outcome. Their data shows a decreasing trend of TB prevalence in this sample set supporting the efficacy of the national strategic plan for TB containment. The study conclusions support previous data on TB incidence and correlation with comorbidities and behavioural traits (tobacco and /or alcohol consumption). Thus, while not novel, the data show the efficacy of the TB NSP and underscore the need for continuing TB surveillance and research. The major critique of the manuscript is there are a lot of typographical errors in the manuscript and these need to be corrected to improve readership.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 5;16(10):e0247245. doi: 10.1371/journal.pone.0247245.r002

Author response to Decision Letter 0


5 Oct 2020

Reviewers comments

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Tuberculosis remains one of the major respiratory diseases in south East Asia including the Indian subcontinent and a variety of environmental factors and co-morbidities determine not only the pathology of TB but also success of TB treatment. In this manuscript, Kumar et. al provide a summary of active TB surveillance done in the south Indian Thiruvallur district. Community based surveillance targeting ~69,000 individuals >15y of age included screening for pulmonary TB using sputum samples and chest X-rays. The authors also collected demographical information as well as smoking, alcohol consumption and established correlation with a positive TB outcome. Their data shows a decreasing trend of TB prevalence in this sample set supporting the efficacy of the national strategic plan for TB containment. The study conclusions support previous data on TB incidence and correlation with comorbidities and behavioural traits (tobacco and /or alcohol consumption). Thus, while not novel, the data show the efficacy of the TB NSP and underscore the need for continuing TB surveillance and research. The major critique of the manuscript is there are a lot of typographical errors in the manuscript and these need to be corrected to improve readership.

Reply to Reviewers comments

Thank you for the appreciation on our work and comments. We are submitting the revised version of the manuscript entitled “Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India”. As suggested by reviewer we carefully checked and English corrections made in the manuscript with track changes. I hope this revised version of the manuscript is most suitable for publication. I am very happy to provide any more details and further clarifications.

Decision Letter 1

Frederick Quinn

4 Jan 2021

PONE-D-20-16942R1

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India

PLOS ONE

Dear Dr. Kumar,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript. If you will need significantly more time to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Frederick Quinn

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: In this manuscript, Dolla et al. summarized an epidemiology study on active pulmonary tuberculosis (PTB) at Tiruvallure district via cluster sampling method. The authors defined PTB according to positive smear test or bacterial culture test. Out of 62494 screened population, the authors determined a PTB prevalence rate as 307 per million population. The authors further reported positive correlation between PTB with decreased BMI, smoking, diabetes and elder population. The study overall is convincing, however the authors need to address the following issues:

(1) The BCG vaccination does not have protection judged by a p value of 0.792. Can the authors comment on the possible reasons?

(2) The authors applied p value test to justify the statistical significance between 2 groups. However, the authors need to specify the mathematical method and type-II error for statistical power design, which they leveraged to justify their statistics with a smaller sample size compared to the original one.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 5;16(10):e0247245. doi: 10.1371/journal.pone.0247245.r004

Author response to Decision Letter 1


15 Jan 2021

Thank you for this valid question. We would like to clarify that it was documented that the protective efficacy of BCG was effective for children protecting from the severe forms of TB.

Reference: Subramani R, Datta M, Swaminathan S. Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction? Indian J Tuberc 2015; 62(4): 226-9.

The authors applied p value test to justify the statistical significance between 2 groups. However, the authors need to specify the mathematical method and type-II error for statistical power design, which they leveraged to justify their statistics with a smaller sample size compared to the original one.

We used a univariate and multivariate logistic regression model to look for any association between TB and risk factors such as age, gender, BMI, diabetes, hypertension, history of TB tobacco smoking, alcohol consumption and cooking fuel used in the household.

We made use of the algorithm suggested by Van Wijngaarden-Dekker-Brent algorithm (Brent, 1973) to test the statistical power of the regression models which are more than 80% as required to ensure the statistical significance.

Attachment

Submitted filename: Reply to reviewers comments 2.docx

Decision Letter 2

Frederick Quinn

4 Feb 2021

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India

PONE-D-20-16942R2

Dear Dr. Kumar,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frederick Quinn

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Frederick Quinn

24 Sep 2021

PONE-D-20-16942R2

Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India

Dear Dr. Dolla:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frederick Quinn

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Reply to reviewers comments 2.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES